.png){kind=icon}
.png){kind=icon}
Return
Design and Rationale of the REVEAL PET Study: A Study of 124I-evuzamitide to Diagnose Cardiac Amyloidosis
.png){kind=icon}
PRE
AI
S
M
S
B
M
O
M
J
B
M
O
S
J
S
M
F
V
A
J
R
DOI：10.1016/j.nuclcard.2026.102773.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
To describe the rationale and design of the multicenter phase 3 Research with EVuzamitide to Evaluate for cardiac AmyLoidosis (REVEAL) trial evaluating the diagnostic performance of 124I-evuzamitide positron emission tomography/computed tomography (PET/CT) for detection of cardiac amyloidosis (CA) in patients undergoing evaluation for suspected disease.
Journal
IF:
2.7
Papers:
5.9K
Citations:
4.1K
Organization
No organization information available
Cited Papers